BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21057758)

  • 1. Therapy-related leukemia cutis after adjuvant chemotherapy in a breast cancer patient.
    Lee HY; Ng HJ; Wong PC; Pang SM
    Acta Derm Venereol; 2010 Nov; 90(6):649-50. PubMed ID: 21057758
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukaemia cutis in a patient treated for breast cancer.
    Weinel S; Malone J; Jain D; Callen JP
    Australas J Dermatol; 2009 Feb; 50(1):52-5. PubMed ID: 19178494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil).
    Hatam N; Ahmadloo N; Ahmad Kia Daliri A; Bastani P; Askarian M
    Arch Gynecol Obstet; 2011 Jul; 284(1):215-20. PubMed ID: 20740365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aleukemic monocytic leukemia cutis.
    Barzilai A; Lyakhovitsky A; Goldberg I; Meytes D; Trau H
    Cutis; 2002 Apr; 69(4):301-4. PubMed ID: 12080951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report.
    Martínez-Poventud G; Fradera J; Pérez S; Fernández A; Pacheco E; Acabá L; López-Enriquez A; Román-Díaz A; Castro-Montalvo J; Vélez-García E
    P R Health Sci J; 2008 Sep; 27(3):256-8. PubMed ID: 18782972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer.
    Rao MV; Shayne M
    Breast Cancer Res Treat; 2009 Sep; 117(1):197-8. PubMed ID: 18592371
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful graft-versus-leukemia effect of second bone marrow transplantation on relapsed leukemia cutis that was refractory to intensive chemotherapy and donor lymphocyte transfusions in a patient with acute monocytic leukemia.
    Ashida T; Kawanishi K; Ariyama T; Hamasaki H; Maeda Y; Tsubaki K; Kanamaru A
    Int J Hematol; 2000 Jun; 71(4):385-8. PubMed ID: 10905060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide chemotherapy.
    Damasiewicz MJ; Chionh FJ; Hayes T
    Intern Med J; 2007 Jul; 37(7):505-6. PubMed ID: 17547732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pancytopenia and macular rash in a woman with a history of breast cancer].
    Jacobi D; Vidal C; Gironet N; Machet MC; Machet L
    Rev Med Interne; 2003 Jun; 24(6):399-400. PubMed ID: 12814830
    [No Abstract]   [Full Text] [Related]  

  • 11. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
    Muss HB; Berry DA; Cirrincione C; Budman DR; Henderson IC; Citron ML; Norton L; Winer EP; Hudis CA;
    J Clin Oncol; 2007 Aug; 25(24):3699-704. PubMed ID: 17704418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. t(8;16) AML developed subsequent to breast cancer therapy.
    Sahin FI; Yilmaz Z; Karakuş S; Boğa S; Akçali Z; DemIrhan B
    Hematology; 2006 Jun; 11(3):153-5. PubMed ID: 17326321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
    J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytic aleukemic leukemia cutis.
    Török L; Lueff S; Garay G; Tápai M
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):54-8. PubMed ID: 10565632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced breast cancer: How much chemotherapy is enough?
    DiPaola RS; Kaufman A; Mikhail MM
    Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
    [No Abstract]   [Full Text] [Related]  

  • 19. Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
    Fornier MN; Seidman AD; Theodoulou M; Moynahan ME; Currie V; Moasser M; Sklarin N; Gilewski T; D'Andrea G; Salvaggio R; Panageas KS; Norton L; Hudis C
    Clin Cancer Res; 2001 Dec; 7(12):3934-41. PubMed ID: 11751485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hand-foot syndrome in breast cancer patients receiving adjuvant chemotherapy.
    Lee CK; Lynch J
    Intern Med J; 2007 Apr; 37(4):281-2. PubMed ID: 17388876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.